India: ADB invests US$75m in OrbiMed’s latest fund

Janette Hall

The Asian Development Bank (ADB) has invested US$75m in OrbiMed’s fourth healthcare fund, OrbiMed Asia Partners IV (OPA IV). The fund is focused on healthcare in India and China. OAP IV is expected to provide mainly growth capital to 15 to 20 health care companies across the biopharma, medical technology, healthcare services, diagnostics, and distribution…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »